ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,514, issued on Oct. 28, was assigned to Cerepeut Inc. (Stanford, Calif.).
"Quinazolinone compounds" was invented by Bingwei Lu (Stanford, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "New quinazolinone compounds are disclosed, as well as pharmaceutical compositions containing quinazolinones and methods for the treatment of diseases and conditions associated with mitochondrial dysfunction."
The patent was filed on Feb. 26, 2020, under Application No. 17/434,145.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool....